Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The 2001 Bethesda System terminology.

Barbara S Apgar1, Lauren Zoschnick, Thomas C Wright

  • 1Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA. bapgar@umich.edu

American Family Physician
|December 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial.

Gynecologic oncology·2023
Same author

Dermatofibrosarcoma Protuberans in Children.

Current treatment options in oncology·2022
Same author

Liposarcoma subtype recurrence and survival: A UK regional cohort study.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2022
Same author

Clinical Utility of Reflex Testing with Cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2022
Same author

Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial.

International journal of cancer·2021
Same author

The CERTAIN Study Results: Adjunctive p16 Immunohistochemistry Use in Cervical Biopsies According to LAST Criteria.

The American journal of surgical pathology·2021

The 2001 Bethesda System updates cervical cancer screening terminology, refining categories for atypical squamous cells (ASC) and atypical glandular cells (AGC). This aims for clearer, more precise cytologic diagnoses in women's health.

Area of Science:

  • Cytopathology
  • Gynecologic Oncology
  • Medical Terminology

Background:

  • The Bethesda System provides standardized terminology for cervical and vaginal cytologic diagnoses.
  • Previous revisions occurred in 1988 and 1991.
  • The 2001 system introduces incremental changes to enhance diagnostic clarity.

Purpose of the Study:

  • To outline the revisions and new categories within the 2001 Bethesda System for cytologic diagnoses.
  • To improve the precision and consistency of reporting cervical and vaginal cytologic findings.
  • To facilitate better communication between laboratories and clinicians.

Main Methods:

  • Review and analysis of the updated 2001 Bethesda System guidelines.
  • Comparison of the 2001 system with previous versions (1988, 1991).

Related Experiment Videos

  • Identification of changes in specimen adequacy, general categorization, and interpretation.

    • Main Results:

    • Elimination of 'satisfactory but limited by' in adequacy. Introduction of 'atypical squamous cells' (ASC) replacing 'atypical squamous cells of undetermined significance' (ASCUS), with new qualifiers ASC-US and ASC-H.
    • Elimination of ASCUS 'favor reactive' and 'favor neoplasia' categories.
    • Replacement of 'atypical glandular cells of undetermined significance' (AGUS) with 'atypical glandular cells' (AGC), specifying cell origin and including 'endocervical adenocarcinoma in situ' and 'AGC, favor neoplastic' as distinct categories.

    Conclusions:

    • The 2001 Bethesda System refines cytologic terminology for improved diagnostic accuracy.
    • New categories for ASC and AGC aim to reduce ambiguity and enhance clinical management.
    • Standardized reporting of endometrial cells in women over 40 is emphasized.